Cargando…
Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
Cancer is a leading cause of death worldwide, particularly because of its high mortality rate in patients who are diagnosed at late stages. Conventional biomarkers originating from blood are widely used for cancer diagnosis, but their low sensitivity and specificity limit their widespread applicatio...
Autores principales: | Wang, Sumeng, Zhang, Ke, Tan, Shanyue, Xin, Junyi, Yuan, Qianyu, Xu, Huanhuan, Xu, Xian, Liang, Qi, Christiani, David C., Wang, Meilin, Liu, Lingxiang, Du, Mulong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798340/ https://www.ncbi.nlm.nih.gov/pubmed/33430880 http://dx.doi.org/10.1186/s12943-020-01298-z |
Ejemplares similares
-
Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature
por: Xu, Huanhuan, et al.
Publicado: (2021) -
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
por: Pardini, Barbara, et al.
Publicado: (2019) -
Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study
por: Xin, Junyi, et al.
Publicado: (2022) -
Correction: Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study
por: Xin, Junyi, et al.
Publicado: (2022) -
Exosomes as a new frontier of cancer liquid biopsy
por: Yu, Dan, et al.
Publicado: (2022)